Thrombolytic Therapy    Comparison of accuracy in the prediction of left ventricular wall motion changes between invasively assessed microvascular integrity indexes and fluorine-18 fluorodeoxyglucose positron emission tomography in patients with ST-elevation myocardial infarction Am J Cardiol (2008) 102; 129-34 M. H. Yoon, S. J. Tahk, H. M. Yang, S. I. Woo, H. S. Lim, S. J. Kang, B. J. Choi, S. Y. Choi, G. S. Hwang and J. H. Shin Long-term clinical and angiographic outcomes after implantation of sirolimus-eluting stents with a "modified mini-crush" technique in coronary bifurcation lesions Catheter Cardiovasc Interv (2009) H. M. Yang, S. J. Tahk, S. I. Woo, H. S. Lim, B. J. Choi, S. Y. Choi, M. H. Yoon, J. S. Park, M. Zheng, G. S. Hwang, S. J. Kang and J. H. Shin Comparison of benefits and risks of rosuvastatin versus atorvastatin from a meta-analysis of head-to-head randomized controlled trials Am J Cardiol (2008) 102; 1654-62 J. Wlodarczyk, D. Sullivan and M. Smith An early invasive strategy versus ischemia-guided management after fibrinolytic therapy for ST-segment elevation myocardial infarction: a meta-analysis of contemporary randomized controlled trials Am Heart J (2008) 156; 564-72, 72 e1-2 H. C. Wijeysundera, J. J. You, B. K. Nallamothu, H. M. Krumholz, W. J. Cantor and D. T. Ko Long-term clinical outcomes after sirolimus-eluting stent implantation for treatment of restenosis within bare-metal versus drug-eluting stents Catheter Cardiovasc Interv (2008) 71; 594-8 C. Whan Lee, S. H. Kim, J. Suh, D. W. Park, S. H. Lee, Y. H. Kim, M. K. Hong, J. J. Kim, S. W. Park and S. J. Park Impact on mortality following first acute myocardial infarction of distance between home and hospital: cohort study Heart (2008) 94; 1141-6 L. Wei, C. C. Lang, F. M. Sullivan, P. Boyle, J. Wang, S. D. Pringle and T. M. MacDonald Role of myocardial perfusion imaging in patients with end-stage renal disease undergoing coronary angiography Am J Cardiol (2008) 102; 1451-6 R. Venkataraman, F. G. Hage, T. Dorfman, J. Heo, R. A. Aqel, A. M. de Mattos and A. E. Iskandrian Prognostic value of free plasma homocysteine levels in patients hospitalized with acute coronary syndrome Am J Cardiol (2008) 102; 135-9 M. G. van Oijen, B. E. Claessen, N. Clappers, A. van Schaik, R. J. Laheij, J. B. Jansen, W. H. Peters and F. W. Verheugt Effect of statin therapy on mortality in patients with peripheral arterial disease and comparison of those with versus without associated chronic obstructive pulmonary disease Am J Cardiol (2008) 102; 192-6 Y. R. van Gestel, S. E. Hoeks, D. D. Sin, C. Simsek, G. M. Welten, O. Schouten, H. Stam, F. W. Mertens, R. T. van Domburg and D. Poldermans Prolonged anticoagulation therapy adjunctive to aspirin after successful fibrinolysis: from early reduction in reocclusion to improved long-term clinical outcome Am Heart J (2009) 157; 532-40 P. J. van den Bergh, P. C. Kievit, M. A. Brouwer, W. R. Aengevaeren, G. Veen and F. W. Verheugt Comparison of angiographic and intravascular ultrasonic detection of myocardial bridging of the left anterior descending coronary artery Am J Cardiol (2008) 102; 1608-13 K. Tsujita, A. Maehara, G. S. Mintz, H. Doi, T. Kubo, C. Castellanos, J. Liu, J. Yang, C. Oviedo, T. Franklin-Bond, N. Dasgupta, S. Biro, L. Dani, G. D. Dangas, R. Mehran, A. J. Kirtane, A. J. Lansky, E. M. Kreps, M. B. Collins, G. W. Stone, J. W. Moses and M. B. Leon Impact of early and delayed stroke on in-hospital and long-term mortality after isolated coronary artery bypass grafting Am J Cardiol (2008) 102; 411-7 I. K. Toumpoulis, C. E. Anagnostopoulos, T. P. Chamogeorgakis, D. C. Angouras, M. A. Kariou, D. G. Swistel and C. K. Rokkas Risk predictors of retroperitoneal hemorrhage following percutaneous coronary intervention Am J Cardiol (2008) 102; 1473-6 K. A. Tiroch, N. Arora, M. E. Matheny, C. Liu, T. C. Lee and F. S. Resnic Percutaneous revascularization is the preferred strategy for patients with significant left main coronary stenosis Circulation (2009) 119; 1021-33 P. S. Teirstein Distribution and frequency of thin-capped fibroatheromas and ruptured plaques in the entire culprit coronary artery in patients with acute coronary syndrome as determined by optical coherence tomography Am J Cardiol (2008) 102; 975-9 A. Tanaka, T. Imanishi, H. Kitabata, T. Kubo, S. Takarada, H. Kataiwa, A. Kuroi, H. Tsujioka, T. Tanimoto, N. Nakamura, M. Mizukoshi, K. Hirata and T. Akasaka Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute coronary syndrome Am J Cardiol (2008) 102; 653-7 U. U. Tamhane, S. Aneja, D. Montgomery, E. K. Rogers, K. A. Eagle and H. S. Gurm Fasting blood glucose and the risk of stroke and myocardial infarction J Circulation (2009) 119; 812-9 . Sung, Y. M. Song, S. Ebrahim and D. A. Lawlor Bleeding risk and outcomes of Bivalirudin versus Glycoprotein IIb/IIIa inhibitors with targeted low-dose unfractionated Heparin in patients having percutaneous coronary intervention for either stable or unstable angina pectoris Am J Cardiol (2008) 102; 160-4 D. H. Steinberg, P. Shah, T. Kinnaird, T. L. Pinto Slottow, P. K. Roy, T. Okabe, L. Bonello, A. de Labriolle, K. A. Smith, R. Torguson, Z. Xue, W. O. Suddath, K. M. Kent, L. F. Satler, A. D. Pichard, J. Lindsay and R. Waksman Prognostic implications of normal (<0.10 ng/ml) and borderline (0.10 to 1.49 ng/ml) troponin elevation levels in critically ill patients without acute coronary syndrome Am J Cardiol (2008) 102; 509-12 R. Stein, B. Gupta, S. Agarwal, J. Golub, D. Bhutani, A. Rosman and C. Eng Angiographic patterns of drug-eluting stent restenosis and one-year outcomes after treatment with repeated percutaneous coronary intervention Am J Cardiol (2008) 102; 311-5 E. Solinas, G. Dangas, A. J. Kirtane, A. J. Lansky, T. Franklin-Bond, P. Boland, G. Syros, Y. H. Kim, A. Gupta, G. Mintz, M. Fahy, M. Collins, S. Kodali, G. W. Stone, J. W. Moses, M. B. Leon and R. Mehran Usefulness of fasting plasma glucose to predict mortality or coronary heart disease in persons > or = 60 years of age without diabetes mellitus or in those with undiagnosed diabetes mellitus (from The Dubbo Study) Am J Cardiol (2008) 102; 831-4 L. A. Simons, J. Simons, Y. Friedlander and J. McCallum Exaggerated blood pressure response to exercise is associated with augmented rise of angiotensin II during exercise J Am Coll Cardiol (2008) 52; 287-92 C. Y. Shim, J. W. Ha, S. Park, E. Y. Choi, D. Choi, S. J. Rim and N. Chung Defining optimal research study design for cardiovascular imaging using computed tomography angiography as a model Am J Cardiol (2008) 102; 943-8 B. R. Shah, M. R. Patel, E. D. Peterson and P. S. Douglas Stents versus coronary-artery bypass grafting for left main coronary artery disease N Engl J Med (2008) 358; 1781-92 K. B. Seung, D. W. Park, Y. H. Kim, S. W. Lee, C. W. Lee, M. K. Hong, S. W. Park, S. C. Yun, H. C. Gwon, M. H. Jeong, Y. Jang, H. S. Kim, P. J. Kim, I. W. Seong, H. S. Park, T. Ahn, I. H. Chae, S. J. Tahk, W. S. Chung and S. J. Park Clinical significance of epicardial fat measured using cardiac multislice computed tomography Am J Cardiol (2008) 102; 767-71 S. Sarin, C. Wenger, A. Marwaha, A. Qureshi, B. D. Go, C. A. Woomert, K. Clark, L. A. Nassef and J. Shirani Relation of cardiac troponin I levels with in-hospital mortality in patients with ischemic stroke, intracerebral hemorrhage, and subarachnoid hemorrhage Am J Cardiol (2008) 102; 632-4 R. Sandhu, W. S. Aronow, A. Rajdev, R. Sukhija, H. Amin, K. D'Aquila and A. Sangha Magnitude, reproducibility, and association with baseline cardiac function of cardiac biomarker release in long-distance runners aged > or =55 years Am J Cardiol (2008) 102; 218-22 A. Sahlen, R. Winter, B. Lind, P. H. Jacobsen, M. Stahlberg, T. Marklund, T. Fux, J. Svensson and F. Braunschweig Two-year outcome of patients treated with sirolimus- versus paclitaxel-eluting stents in an unselected population with coronary artery disease (from the REWARDS Registry) Am J Cardiol (2008) 102; 292-7 P. Roy, L. Bonello, A. de Labriolle, T. Okabe, T. L. Pinto Slottow, D. H. Steinberg, R. Torguson, K. Smith, Z. Xue, L. F. Satler, K. M. Kent, W. O. Suddath, A. D. Pichard and R. Waksman Long-term outcomes in patients undergoing coronary stenting on dual oral antiplatelet treatment requiring oral anticoagulant therapy Am J Cardiol (2008) 102; 1618-23 R. Rossini, G. Musumeci, C. Lettieri, M. Molfese, L. Mihalcsik, P. Mantovani, V. Sirbu, T. A. Bass, F. Della Rovere, A. Gavazzi and D. J. Angiolillo Cardiovascular risk in women with non-specific chest pain (from the Women's Health Initiative Hormone Trials) Am J Cardiol (2008) 102; 693-9 J. G. Robinson, R. Wallace, M. Limacher, H. Ren, B. Cochrane, S. Wassertheil-Smoller, J. K. Ockene, P. L. Blanchette and M. G. Ko The case for chronic kidney disease, diabetes mellitus, and myocardial infarction being equivalent risk factors for cardiovascular mortality in patients older than 65 years Am J Cardiol (2008) 102; 1668-73 A. Rashidi, A. R. Sehgal, M. Rahman and A. S. O'Connor Change in high-density lipoprotein cholesterol and incident coronary heart disease in apparently healthy male physicians Am J Cardiol (2008) 102; 1663-7 C. Rahilly-Tierney, T. S. Bowman, L. Djousse, H. D. Sesso and J. M. Gaziano Geographic differences in clinical presentation, treatment, and outcomes in type A acute aortic dissection (from the International Registry of Acute Aortic Dissection) Am J Cardiol (2008) 102; 1562-6 A. Raghupathy, C. A. Nienaber, K. M. Harris, T. Myrmel, R. Fattori, U. Sechtem, J. Oh, S. Trimarchi, J. V. Cooper, A. Booher, K. Eagle, E. Isselbacher and E. Bossone Dynamics of platelet functional recovery following a clopidogrel loading dose in healthy volunteers Am J Cardiol (2008) 102; 790-5 M. J. Price and P. S. Teirstein Observations and outcomes of definite and probable drug-eluting stent thrombosis seen at a single hospital in a four-year period Am J Cardiol (2008) 102; 298-303 T. L. Pinto Slottow, D. H. Steinberg, P. K. Roy, A. N. Buch, T. Okabe, Z. Xue, K. Kaneshige, R. Torguson, J. Lindsay, A. D. Pichard, L. F. Satler, W. O. Suddath, K. M. Kent and R. Waksman Meta-analysis comparison (nine trials) of outcomes with drug-eluting stents versus bare metal stents in patients with diabetes mellitus Am J Cardiol (2008) 102; 1328-34 G. Patti, A. Nusca and G. Di Sciascio Disparities in use of same-day percutaneous coronary intervention for patients with ST-elevation myocardial infarction in Florida, 2001-2005 Am J Cardiol (2008) 102; 802-8 E. B. Pathak and J. A. Strom Current status of percutaneous coronary intervention with drug-eluting stents in Asia Circulation (2008) 118; 2730-7 S. J. Park and Y. H. Kim Long-term mortality after percutaneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass surgery for the treatment of multivessel coronary artery disease Circulation (2008) 117; 2079-86 D. W. Park, S. C. Yun, S. W. Lee, Y. H. Kim, C. W. Lee, M. K. Hong, J. J. Kim, S. J. Choo, H. Song, C. H. Chung, J. W. Lee, S. W. Park and S. J. Park Chronic kidney disease as a predictor of cardiovascular disease (from the Framingham Heart Study) Am J Cardiol (2008) 102; 47-53 N. I. Parikh, S. J. Hwang, M. G. Larson, D. Levy and C. S. Fox Two-year clinical outcome with drug-eluting stents versus bare-metal stents in a real-world registry of unprotected left main coronary artery stenosis from the Italian Society of Invasive Cardiology Am J Cardiol (2008) 102; 1463-8 T. Palmerini, A. Marzocchi, C. Tamburino, I. Sheiban, M. Margheri, G. Vecchi, G. Sangiorgi, A. Santarelli, A. Bartorelli, C. Briguori, L. Vignali, F. Di Pede, A. Ramondo, L. Inglese, M. De Carlo, L. Bolognese, A. Benassi, C. Palmieri, V. Filippone, D. Sangiorgi and S. De Servi Comparison of intravascular ultrasound to contrast-enhanced 64-slice computed tomography to assess the significance of angiographically ambiguous coronary narrowings Am J Cardiol (2008) 102; 994-1001 T. Okabe, W. G. Weigold, G. S. Mintz, R. Roswell, S. Joshi, S. Y. Lee, B. Lee, D. H. Steinberg, P. Roy, T. L. Slottow, K. Smith, R. Torguson, Z. Xue, L. F. Satler, K. M. Kent, A. D. Pichard, N. J. Weissman, J. Lindsay and R. Waksman Drug-eluting stents versus bare metal stents for narrowing in saphenous vein grafts Am J Cardiol (2008) 102; 530-4 T. Okabe, J. Lindsay, A. N. Buch, D. H. Steinberg, P. Roy, T. L. Slottow, K. Smith, R. Torguson, Z. Xue, L. F. Satler, K. M. Kent, A. D. Pichard, N. J. Weissman and R. Waksman Clopidogrel treatment and the MEND-CABG II trial JAMA (2008) 300; 1021; author reply 21-2 J. Oh, N. Hong and S. M. Kang Association between baseline neutrophil count, clopidogrel therapy, and clinical and angiographic outcomes in patients with ST-elevation myocardial infarction receiving fibrinolytic therapy Eur Heart J (2008) 29; 984-91 M. O'Donoghue, D. A. Morrow, C. P. Cannon, W. Guo, S. A. Murphy, C. M. Gibson and M. S. Sabatine Association of coronary atherosclerosis detected by multislice computed tomography and traditional risk-factor assessment Am J Cardiol (2008) 102; 316-20 D. Nair, T. P. Carrigan, R. J. Curtin, Z. B. Popovic, S. Kuzmiak, P. Schoenhagen, S. D. Flamm and M. Y. Desai Serum cystatin C and increased coronary heart disease prevalence in US adults without chronic kidney disease Am J Cardiol (2008) 102; 54-7 P. Muntner, D. Mann, J. Winston, S. Bansilal and M. E. Farkouh Concurrent evaluation of novel cardiac biomarkers in acute coronary syndrome: myeloperoxidase and soluble CD40 ligand and the risk of recurrent ischaemic events in TACTICS-TIMI 18 Eur Heart J (2008) 29; 1096-102 D. A. Morrow, M. S. Sabatine, M. L. Brennan, J. A. de Lemos, S. A. Murphy, C. T. Ruff, N. Rifai, C. P. Cannon and S. L. Hazen Usefulness of proteinuria as a prognostic marker of mortality and cardiovascular events among patients undergoing percutaneous coronary intervention (data from the Evaluation of Oral Xemilofiban in Controlling Thrombotic Events [EXCITE] trial) Am J Cardiol (2008) 102; 1151-5 N. Mercado, J. J. Brugts, J. H. Ix, M. G. Shlipak, S. R. Dixon, B. J. Gersh, P. A. Lemos, M. Guarneri, P. S. Teirstein, W. Wijns, P. W. Serruys, E. Boersma and W. W. O'Neill Adverse outcomes in fibrinolytic-based facilitated percutaneous coronary intervention: insights from the ASSENT-4 PCI electrocardiographic substudy Eur Heart J (2008) 29; 871-9 M. A. McDonald, Y. Fu, U. Zeymer, G. Wagner, S. G. Goodman, A. Ross, C. B. Granger, F. Van de Werf and P. W. Armstrong Effectiveness of reloading to overcome clopidogrel nonresponsiveness in patients with acute myocardial infarction Am J Cardiol (2008) 102; 524-9 S. Matetzky, P. Fefer, B. Shenkman, D. Varon, N. Savion and H. Hod Percutaneous removal of embolized port catheter: The standard option Catheter Cardiovasc Interv (2008) 72; 1025-6 P. Y. Marcy, J. Thariat and N. Amoretti Comparison of stent thrombosis, myocardial infarction, and mortality following drug-eluting versus bare-metal stent coronary intervention in patients with diabetes mellitus Am J Cardiol (2008) 102; 165-72 M. Maeng, L. O. Jensen, A. Kaltoft, H. H. Hansen, M. Bottcher, J. F. Lassen, P. Thayssen, L. R. Krusell, K. Rasmussen, L. Pedersen, H. T. Sorensen, S. P. Johnsen and L. Thuesen Advanced age, antithrombotic strategy, and bleeding in non-ST-segment elevation acute coronary syndromes: results from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial J Am Coll Cardiol (2009) 53; 1021-30 R. D. Lopes, K. P. Alexander, S. V. Manoukian, M. E. Bertrand, F. Feit, H. D. White, C. V. Pollack, Jr., J. Hoekstra, B. J. Gersh, G. W. Stone and E. M. Ohman Off-pump coronary artery bypass graft surgery in California, 2003 to 2005 Am Heart J (2008) 156; 1095-102 Z. Li, K. K. Yeo, J. P. Parker, G. Mahendra, J. N. Young and E. A. Amsterdam Comparison of the predictive value of four different risk scores for outcomes of patients with ST-elevation acute myocardial infarction undergoing primary percutaneous coronary intervention Am J Cardiol (2008) 102; 6-11 E. I. Lev, R. Kornowski, H. Vaknin-Assa, A. Porter, I. Teplitsky, I. Ben-Dor, D. Brosh, S. Fuchs, A. Battler and A. Assali Does thrombolytic therapy facilitate or foil primary PCI? N Engl J Med (2008) 358; 2277-9 J. A. Leopold A randomized comparison of sirolimus- versus Paclitaxel-eluting stent implantation in patients with diabetes mellitus J Am Coll Cardiol (2008) 52; 727-33 S. W. Lee, S. W. Park, Y. H. Kim, S. C. Yun, D. W. Park, C. W. Lee, M. K. Hong, K. S. Rhee, J. K. Chae, J. K. Ko, J. H. Park, J. H. Lee, S. W. Choi, J. O. Jeong, I. W. Seong, Y. H. Cho, N. H. Lee, J. H. Kim, K. J. Chun, H. S. Kim and S. J. Park Drug-eluting stenting followed by cilostazol treatment reduces late restenosis in patients with diabetes mellitus the DECLARE-DIABETES Trial (A Randomized Comparison of Triple Antiplatelet Therapy with Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Diabetic Patients) J Am Coll Cardiol (2008) 51; 1181-7 S. W. Lee, S. W. Park, Y. H. Kim, S. C. Yun, D. W. Park, C. W. Lee, M. K. Hong, H. S. Kim, J. K. Ko, J. H. Park, J. H. Lee, S. W. Choi, I. W. Seong, Y. H. Cho, N. H. Lee, J. H. Kim, K. J. Chun and S. J. Park Double anchoring balloon technique for recanalization of coronary chronic total occlusion by retrograde approach Catheter Cardiovasc Interv (2008) N. H. Lee, J. Suh and H. S. Seo Prospective randomized comparison of sirolimus- versus paclitaxel-eluting stents for the treatment of acute ST-elevation myocardial infarction: pROSIT trial Catheter Cardiovasc Interv (2008) 72; 25-32 J. H. Lee, H. S. Kim, S. W. Lee, J. H. Park, S. W. Choi, J. O. Jeong, Y. Cho, N. Lee, K. S. Rhee, J. K. Ko and I. W. Seong Coronary revascularization in context N Engl J Med (2009) 360; 1024-6 R. A. Lange and L. D. Hillis The incidence and predictors of postprocedural incomplete stent apposition after angiographically successful drug-eluting stent implantation Catheter Cardiovasc Interv (2008) Y. S. Kim, B. K. Koo, J. B. Seo, K. W. Park, J. W. Suh, H. Y. Lee, J. S. Park, H. J. Kang, Y. S. Cho, W. Y. Chung, I. H. Chae, D. J. Choi, H. S. Kim, B. H. Oh and Y. B. Park The virtual histology intravascular ultrasound appearance of newly placed drug-eluting stents Am J Cardiol (2008) 102; 1182-6 S. W. Kim, G. S. Mintz, Y. J. Hong, R. Pakala, K. S. Park, A. D. Pichard, L. F. Satler, K. M. Kent, W. O. Suddath, R. Waksman and N. J. Weissman Frequency of myocardial bridges and dynamic compression of epicardial coronary arteries: a comparison between computed tomography and invasive coronary angiography Circulation (2009) 119; 1408-16 P. J. Kim, G. Hur, S. Y. Kim, J. Namgung, S. W. Hong, Y. H. Kim and W. R. Lee Intravascular ultrasound evaluation of optimal drug-eluting stent expansion after poststent balloon dilation using a noncompliant balloon versus a semicompliant balloon (from the Poststent Optimal Stent Expansion Trial [POET]) Am J Cardiol (2008) 102; 304-10 J. S. Kim, J. Y. Moon, Y. G. Ko, D. Choi, Y. Jang, W. C. Kang, T. Ahn, B. K. Kim, S. J. Oh, D. W. Jeon and J. Y. Yang Comparison of sirolimus-eluting stent and paclitaxel-eluting stent for long-term cardiac adverse events in diabetic patients: the Korean Multicenter Angioplasty Team (KOMATE) Registry J Catheter Cardiovasc Interv (2008) 72; 601-7 . S. Kim, B. H. Lee, Y. G. Ko, D. Choi, Y. Jang, P. K. Min, Y. W. Yoon, B. K. Hong, H. M. Kwon, M. S. Ahn, S. H. Lee, J. H. Yoon, B. K. Lee, B. O. Kim, B. K. Kim, S. J. Oh, D. W. Jeon, J. Y. Yang, J. R. Cho, J. H. Jung and S. K. Ryu A percutaneous coronary intervention-thrombolytic predictive instrument to assist choosing between immediate thrombolytic therapy versus delayed primary percutaneous coronary intervention for acute myocardial infarction Am J Cardiol (2008) 101; 790-5 D. M. Kent, R. Ruthazer, J. L. Griffith, J. R. Beshansky, T. W. Concannon, T. Aversano, C. L. Grines, R. J. Zalenski and H. P. Selker ST resolution 1 hour after fibrinolysis for prediction of myocardial infarct size: insights from ASSENT 3 Am J Cardiol (2009) 103; 154-8 P. Johanson, Y. Fu, G. S. Wagner, S. G. Goodman, C. B. Granger, L. Wallentin, F. Van de Werf and P. W. Armstrong Randomized comparison of adjunctive cilostazol versus high maintenance dose clopidogrel in patients with high post-treatment platelet reactivity: results of the ACCEL-RESISTANCE (Adjunctive Cilostazol Versus High Maintenance Dose Clopidogrel in Patients With Clopidogrel Resistance) randomized study J Am Coll Cardiol (2009) 53; 1101-9 Y. H. Jeong, S. W. Lee, B. R. Choi, I. S. Kim, M. K. Seo, C. H. Kwak, J. Y. Hwang and S. W. Park Intravascular ultrasound assessment of expansion of the sirolimus-eluting (cypher select) and paclitaxel-eluting (Taxus Express-2) stent in patients with diabetes mellitus Am J Cardiol (2008) 102; 19-26 L. O. Jensen, M. Maeng, G. S. Mintz, E. H. Christiansen, K. N. Hansen, A. Galloe, H. Kelbaek, H. S. Hansen, E. Joergensen, J. F. Lassen, L. Thuesen and P. Thayssen Prevalence, predictors, and outcomes of primary nonadherence after acute myocardial infarction Circulation (2008) 117; 1028-36 C. A. Jackevicius, P. Li and J. V. Tu Effects of intracoronary injection of mononuclear bone marrow cells on left ventricular function, arrhythmia risk profile, and restenosis after thrombolytic therapy of acute myocardial infarction Eur Heart J (2008) 29; 2723-32 H. V. Huikuri, K. Kervinen, M. Niemela, K. Ylitalo, M. Saily, P. Koistinen, E. R. Savolainen, H. Ukkonen, M. Pietila, J. K. Airaksinen, J. Knuuti and T. H. Makikallio The impact of pre-hospital thrombolytic treatment on re-infarction rates: analysis of the Myocardial Infarction National Audit Project (MINAP) Heart (2009) 95; 559-63 S. Horne, C. Weston, T. Quinn, A. Hicks, L. Walker, R. Chen and J. Birkhead Late target lesion revascularization after implantation of sirolimus-eluting stent Catheter Cardiovasc Interv (2008) 71; 299-303 M. K. Hong, G. S. Mintz, C. W. Lee, D. W. Park, S. W. Lee, Y. H. Kim, I. H. Jung, S. H. Kim, S. S. Cheong, J. J. Kim, S. W. Park and S. J. Park Percutaneous coronary intervention versus coronary artery bypass grafting as primary revascularization in patients with acute coronary syndrome Am J Cardiol (2008) 102; 173-9 W. Hochholzer, H. J. Buettner, D. Trenk, T. Breidthardt, M. Noveanu, K. Laule, M. Christ, C. Schindler, F. J. Neumann and C. Mueller Seconds-Count.org offers enhanced tools for patients and physicians Catheter Cardiovasc Interv (2008) 72; 1027-9 Z. M. Hijazi and J. J. Marshall Relation of left ventricular infarct transmurality and infarct size after primary percutaneous coronary angioplasty to time from symptom onset to balloon inflation Am J Cardiol (2008) 102; 1163-9 J. Y. Hahn, Y. B. Song, H. C. Gwon, Y. H. Choe, J. H. Kim, J. Sung, S. H. Choi, J. H. Choi, D. K. Kim, K. P. Hong, J. E. Park and S. H. Lee Clinical and angiographic follow-up of small vessel lesions treated with paclitaxel-eluting stents (from the TRUE Registry) Am J Cardiol (2008) 102; 1002-8 C. Godino, S. Furuichi, A. Latib, N. Morici, A. Chieffo, E. Romagnoli, C. Tamburino, R. Barbagallo, M. Cera, D. Antoniucci, O. Goktekin, C. Di Mario, B. Reimers, E. Grube, F. Airoldi, G. M. Sangiorgi and A. Colombo Association of impaired thrombolysis in myocardial infarction myocardial perfusion grade with ventricular tachycardia and ventricular fibrillation following fibrinolytic therapy for ST-segment elevation myocardial infarction J Am Coll Cardiol (2008) 51; 546-51 C. M. Gibson, Y. B. Pride, J. L. Buros, E. Lord, A. Shui, S. A. Murphy, D. S. Pinto, P. J. Zimetbaum, M. S. Sabatine, C. P. Cannon and M. E. Josephson Relation of hyperemic epicardial flow to outcomes among patients with ST-segment elevation myocardial infarction receiving fibrinolytic therapy Am J Cardiol (2008) 101; 1232-8 C. M. Gibson, Y. B. Pride, J. L. Buros, V. Kunadian, M. C. Southard, C. J. Harrigan, L. N. Ciaglo, M. S. Sabatine, C. P. Cannon and E. Braunwald Effects of pretreatment with clopidogrel on nonemergent percutaneous coronary intervention after fibrinolytic administration for ST-segment elevation myocardial infarction: a Clopidogrel as Adjunctive Reperfusion Therapy-Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 study Am Heart J (2008) 155; 133-9 C. M. Gibson, S. A. Murphy, Y. B. Pride, A. J. Kirtane, J. M. Aroesty, E. B. Stein, L. N. Ciaglo, M. C. Southard, M. S. Sabatine, C. P. Cannon and E. Braunwald Usefulness of revascularization of patients with multivessel coronary artery disease before elective vascular surgery for abdominal aortic and peripheral occlusive disease Am J Cardiol (2008) 102; 809-13 S. Garcia, T. E. Moritz, H. B. Ward, G. Pierpont, S. Goldman, G. C. Larsen, F. Littooy, W. Krupski, L. Thottapurathu, D. J. Reda and E. O. McFalls Long-term outcome of primary angioplasty compared with fibrinolysis across age groups: a Danish Multicenter Randomized Study on Fibrinolytic Therapy Versus Acute Coronary Angioplasty in Acute Myocardial Infarction (DANAMI-2) substudy Am Heart J (2008) 156; 391-6 E. L. Fosbol, J. J. Thune, H. Kelbaek, H. R. Andersen, K. Saunamaki, T. T. Nielsen, L. S. Mortensen and L. Kober The pharmaco-invasive approach to STEMI: when should fibrinolytic-treated patients go to the "cath lab"? Heart (2009) 95; 358-61 J. J. Edmond, C. P. Juergens and J. K. French Comparison of increased aspirin dose versus combined aspirin plus clopidogrel therapy in patients with diabetes mellitus and coronary heart disease and impaired antiplatelet response to low-dose aspirin Am J Cardiol (2008) 102; 396-400 M. A. Duzenli, K. Ozdemir, N. Aygul, A. Soylu and M. Tokac Comparison of safety, efficacy, and outcome of successful versus unsuccessful percutaneous coronary intervention in "true" chronic total occlusions Am J Cardiol (2008) 102; 1175-81 A. de Labriolle, L. Bonello, P. Roy, G. Lemesle, D. H. Steinberg, Z. Xue, K. Kaneshige, W. O. Suddath, L. F. Satler, K. M. Kent, A. D. Pichard, J. Lindsay and R. Waksman Pre-hospital thrombolysis in perspective Eur Heart J (2008) 29; 2835-42 N. Danchin, E. Durand and D. Blanchard Comparison of thrombolysis followed by broad use of percutaneous coronary intervention with primary percutaneous coronary intervention for ST-segment-elevation acute myocardial infarction: data from the french registry on acute ST-elevation myocardial infarction (FAST-MI) Circulation (2008) 118; 268-76 N. Danchin, P. Coste, J. Ferrieres, P. G. Steg, Y. Cottin, D. Blanchard, L. Belle, B. Ritz, G. Kirkorian, M. Angioi, P. Sans, B. Charbonnier, H. Eltchaninoff, P. Gueret, K. Khalife, P. Asseman, J. Puel, P. Goldstein, J. P. Cambou and T. Simon Long-term outcomes after percutaneous coronary intervention of bifurcation narrowings Am J Cardiol (2008) 102; 404-10 N. Collins, P. H. Seidelin, P. Daly, J. Ivanov, A. Barolet, K. Mackie, S. Bui, L. Schwartz and V. Dzavik Relationship between biomarkers of oxidized low-density lipoprotein, statin therapy, quantitative coronary angiography, and atheroma: volume observations from the REVERSAL (Reversal of Atherosclerosis with Aggressive Lipid Lowering) study J Am Coll Cardiol (2008) 52; 24-32 S. H. Choi, A. Chae, E. Miller, M. Messig, F. Ntanios, A. N. DeMaria, S. E. Nissen, J. L. Witztum and S. Tsimikas Comparison of 64-slice multidetector computed tomography with spectral analysis of intravascular ultrasound backscatter signals for characterizations of noncalcified coronary arterial plaques Am J Cardiol (2008) 102; 988-93 B. J. Choi, D. K. Kang, S. J. Tahk, S. Y. Choi, M. H. Yoon, H. S. Lim, S. J. Kang, H. M. Yang, J. S. Park, M. Zheng, G. S. Hwang and J. H. Shin Usefulness of 64-slice multidetector computed tomography as an initial diagnostic approach in patients with acute chest pain Am Heart J (2008) 156; 375-83 S. A. Chang, S. I. Choi, E. K. Choi, H. K. Kim, J. W. Jung, E. J. Chun, K. S. Kim, Y. S. Cho, W. Y. Chung, T. J. Youn, I. H. Chae, D. J. Choi and H. J. Chang Rationale and design of the Trial of Routine ANgioplasty and Stenting After Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI) Am Heart J (2008) 155; 19-25 W. J. Cantor, D. Fitchett, B. Borgundvaag, M. Heffernan, E. A. Cohen, L. J. Morrison, J. Ducas, A. Langer, S. Mehta, C. Lazzam, B. Schwartz, V. Dzavik and S. G. Goodman The Danish multicentre randomized study of fibrinolytic therapy vs. primary angioplasty in acute myocardial infarction (the DANAMI-2 trial): outcome after 3 years follow-up Eur Heart J (2008) 29; 1259-66 M. Busk, M. Maeng, K. Rasmussen, H. Kelbaek, P. Thayssen, U. Abildgaard, E. Vigholt, L. S. Mortensen, L. Thuesen, S. D. Kristensen, T. T. Nielsen and H. R. Andersen Sustained coronary patency after fibrinolytic therapy as independent predictor of 10-year cardiac survival Observations from the Antithrombotics in the Prevention of Reocclusion in COronary Thrombolysis (APRICOT) trial Am Heart J (2008) 155; 1039-46 M. A. Brouwer, P. C. Kievit, H. J. Dieker, G. Veen, A. J. Karreman and F. W. Verheugt Outcomes of patients with acute coronary syndrome and previous coronary artery bypass grafting (from the Pravastatin or Atorvastatin Evaluation and Infection Therapy [PROVE IT-TIMI 22] and the Aggrastat to Zocor [A to Z] trials) Am J Cardiol (2008) 102; 552-8 E. S. Brilakis, J. A. de Lemos, C. P. Cannon, S. D. Wiviott, S. A. Murphy, D. A. Morrow, M. S. Sabatine, S. Banerjee, M. A. Blazing, R. M. Califf and E. Braunwald Predictors of infarct artery patency after prehospital thrombolysis. The multicentre, prospective, observational OPTIMAL study Heart (2008) V. Bongard, J. Puel, D. Savary, L. Belle, S. Charpentier, Y. Cottin, L. Soulat, M. Elbaz, D. Miljkovic and P. G. Steg Impact of a 600-mg loading dose of clopidogrel on 30-day outcome in unselected patients undergoing percutaneous coronary intervention Am J Cardiol (2008) 102; 1318-22 L. Bonello, G. Lemesle, A. De Labriolle, P. Roy, D. H. Steinberg, T. L. Pinto Slottow, Z. Xue, R. Torguson, W. O. Suddath, L. F. Satler, K. M. Kent, A. D. Pichard, J. Lindsay and R. Waksman Bivalirudin with provisional glycoprotein IIb/IIIa inhibitors in patients undergoing primary angioplasty in the setting of cardiogenic shock Am J Cardiol (2008) 102; 287-91 L. Bonello, A. De Labriolle, P. Roy, D. H. Steinberg, T. L. Pinto Slottow, Z. Xue, K. Smith, R. Torguson, W. O. Suddath, L. F. Satler, K. M. Kent, A. D. Pichard and R. Waksman Assessment of culprit and remote coronary narrowings using optical coherence tomography with long-term outcomes Am J Cardiol (2008) 102; 391-5 P. Barlis, P. W. Serruys, N. Gonzalo, W. J. van der Giessen, P. J. de Jaegere and E. Regar Comparison of the impact of short (<1 year) and long-term (> or =1 year) clopidogrel use following percutaneous coronary intervention on mortality Am J Cardiol (2008) 102; 1159-62 S. Banerjee, C. Varghese, J. Samuel, R. A. Weideman, B. B. Little, K. C. Kelly, S. V. Rao, R. F. Reilly and E. S. Brilakis Effects of bariatric surgery on cardiovascular function Circulation (2008) 118; 2091-102 H. Ashrafian, C. W. le Roux, A. Darzi and T. Athanasiou Relation between aspirin dose, all-cause mortality, and bleeding in patients with recent cerebrovascular or coronary ischemic events (from the BRAVO Trial) Am J Cardiol (2008) 102; 1285-90 H. D. Aronow, R. M. Califf, R. A. Harrington, M. Vallee, C. Graffagnino, A. Shuaib, D. J. Fitzgerald, J. D. Easton, F. Van de Werf, H. C. Diener, J. Ferguson, P. J. Koudstaal, P. Amarenco, P. Theroux, S. Davis and E. J. Topol Incidence of coronary stent thrombosis based on academic research consortium definitions Am J Cardiol (2008) 102; 683-8 R. J. Applegate, M. T. Sacrinty, W. C. Little, R. M. Santos, S. K. Gandhi and M. A. Kutcher Impact of mild or moderate renal insufficiency on the intravascular ultrasonic analysis of chronic vascular response to paclitaxel-eluting and bare-metal stents (from the TAXUS IV, V, and VI trials) Am J Cardiol (2008) 102; 1009-16 J. Aoki, G. S. Mintz, N. J. Weissman, L. Mandinov, E. Grube, K. D. Dawkins, S. G. Ellis, J. Greenberg, A. Yu, J. T. Mann, L. Cannon, P. A. Cambier and G. W. Stone Patterns of upstream antiplatelet therapy use before primary percutaneous coronary intervention for acute ST-elevation myocardial infarction (from the CRUSADE National Quality Improvement Initiative) Am J Cardiol (2008) 102; 1335-40 D. Alexander, N. Mann, F. S. Ou, E. D. Peterson, E. M. Ohman, W. B. Gibler and M. T. Roe Comparison of assessment of native coronary arteries by standard versus three-dimensional coronary angiography Am J Cardiol (2008) 102; 272-9 P. Agostoni, G. Biondi-Zoccai, G. Van Langenhove, K. Cornelis, P. Vermeersch, C. Convens, C. Vassanelli, P. Van Den Heuvel, F. Van Den Branden and S. Verheye Comparison of higher clopidogrel loading and maintenance dose to standard dose on platelet function and outcomes after percutaneous coronary intervention using drug-eluting stents Am J Cardiol (2008) 102; 401-3 M. Abuzahra, M. Pillai, A. Caldera, W. B. Hartley, R. Gonzalez, J. Bobek, H. Dokainish and N. Lakkis